Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/a-0803-6610 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Erosion of Professionalism or a New Norm.
J Gen Intern Med
January 2025
Department of Medicine, Clement J. Zablocki VA Medical Center, Milwaukee, WI, USA.
Raynaud Syndrome Associated with Medication for Attention-Deficit/Hyperactivity Disorder: A Systematic Review.
CNS Drugs
January 2025
Faculty of Environmental and Life Sciences, Centre for Innovation in Mental Health, School of Psychology, University of Southampton, Southampton, UK.
Background: Raynaud syndrome (RS) is a peripheral vasculopathy characterised be impaired acral perfusion typically manifesting as skin discolouration with pallor, cyanosis and/or erythema, and increased sensitivity to cold. RS may be primary or secondary to systemic disease, lifestyle and environmental factors or medication. RS has been reported with medication to treat ADHD, but we found no recent comprehensive overview of the literature.
View Article and Find Full Text PDFProtocol optimization and myocardial blood flow quantification in dynamic myocardial perfusion CT-where do we stand?
Eur Radiol
January 2025
Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Current landscape of congenital heart disease management during pregnancy.
Future Cardiol
January 2025
Department of Obstetrics, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!